Top 18 Vizgen investors
The most complete profiles first. Showing 18 of 18.
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Shaan GandhiVerified
Venture Capital · United States
Health CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Connor McDermott
Venture Capital, Investor · United States
SeedHealth CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Kristina Burow
Venture Capital, Private Equity Firm, Investor · United States
SeedPre-SeedHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: Lycera, Kilimanjaro Energy, Orbital Therapeutics, Vividion Therapeutics and 6 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Sharon Kedar, CFA
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Mike Rubin, MD, PhD, CFA
Venture Capital, Private Equity Firm · United States
Health CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Patrick Smerkers
Venture Capital, Private Equity Firm · United States
Health CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Robert Nelsen
Venture Capital, Investor · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more
Contact details available
Samantha Shalom
Venture Capital · United States
Health CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Andrea Jackson
Venture Capital, Investor · United States
SeedElectronic Health Records (EHR)Health and Hospital ServicesDigital HealthPortfolio: Current Health, Outcomes4Me, Vizgen, Scitara and 2 more
Contact details available
David Walt
Angel/Individual · United States
ChemicalLife ScienceBiotechnologyNanotechnologyPortfolio: Vizgen, Stoicheia
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Ultivue15
- Encodia15
- Vividion Therapeutics10
- Remix Therapeutics10
- Autobahn Therapeutics10
- Vir Biotechnology10
- Gossamer Bio10
- ROME Therapeutics9
- UNITY Biotechnology9
- LifeMine Therapeutics9
- AnchorDx9
Frequently asked questions
How many Vizgen investors are on Angel Roster?
Angel Roster lists 18 Vizgen investors. 6 of them (33%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (8) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Vizgen investors invest in?
Among those that list a stage, the most common are Series B (6), Seed (4) and Pre-Seed (1).
Where are Vizgen investors based?
Most are based in the United States (17) and the United Kingdom (1).
Which companies have Vizgen investors backed?
The most-backed portfolio companies among them are Ultivue (15), Encodia (15), Vividion Therapeutics (10), Remix Therapeutics (10) and Autobahn Therapeutics (10).
How do I contact Vizgen investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.